SEC Form 4 · accession 0001645627-18-000020
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 9, 2018
Accepted (ET)
Apr 12, 2018 · 2:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 9, 2018 | P | 1,000 | $0.0373 | A | 24,940,689 | D | |
| Common Stock | Apr 9, 2018 | P | 1,000 | $0.0378 | A | 24,941,689 | D | |
| Common Stock | Apr 9, 2018 | P | 1,000 | $0.0369 | A | 24,942,689 | D | |
| Common Stock | Apr 9, 2018 | P | 100 | $0.0379 | A | 24,942,789 | D | |
| Common Stock | Apr 10, 2018 | P | 1,000 | $0.04 | A | 24,943,789 | D | |
| Common Stock | Apr 10, 2018 | P | 1,000 | $0.0397 | A | 24,944,789 | D |
Table II — derivative securities
No Table II lines on this filing.